Dr. Goy leads the John Theurer Cancer Center, New Jersey’s largest cancer care program. A specialist in lymphoma care, he also directs the state's largest lymphoma treatment and research program. Widely known for his work in mantle cell lymphoma, he was the lead investigator in the development of three FDA-approved drugs for this disease: bortezomib, lenalidomide, and ibrutinib. He is now assessing biomarkers for lymphoma as well as novel anticancer agents, drug combinations, and non-chemotherapy options.